Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2496.60 | 578 / 578 | 100% | 18.32 | 1152 / 1155 |
esophagus | 100% | 974.36 | 1441 / 1445 | 100% | 20.69 | 183 / 183 |
stomach | 100% | 899.49 | 358 / 359 | 100% | 18.96 | 286 / 286 |
intestine | 100% | 1676.48 | 962 / 966 | 100% | 17.70 | 526 / 527 |
breast | 100% | 1247.97 | 459 / 459 | 99% | 14.77 | 1111 / 1118 |
ovary | 99% | 614.67 | 178 / 180 | 100% | 21.23 | 429 / 430 |
bladder | 100% | 1048.14 | 21 / 21 | 98% | 14.99 | 495 / 504 |
kidney | 100% | 1060.92 | 89 / 89 | 97% | 14.97 | 878 / 901 |
uterus | 100% | 813.12 | 170 / 170 | 96% | 12.81 | 442 / 459 |
thymus | 100% | 1093.28 | 652 / 653 | 96% | 9.90 | 581 / 605 |
prostate | 100% | 921.90 | 245 / 245 | 96% | 9.64 | 480 / 502 |
liver | 100% | 742.19 | 226 / 226 | 92% | 8.96 | 375 / 406 |
skin | 100% | 1315.83 | 1808 / 1809 | 92% | 11.34 | 436 / 472 |
pancreas | 93% | 576.49 | 306 / 328 | 95% | 14.73 | 169 / 178 |
adrenal gland | 100% | 1267.15 | 257 / 258 | 43% | 3.04 | 99 / 230 |
adipose | 100% | 1398.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.63 | 29 / 29 |
spleen | 100% | 5184.62 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.10 | 1 / 1 |
peripheral blood | 100% | 5550.52 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 710.42 | 1308 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.95 | 44 / 45 |
heart | 72% | 300.25 | 619 / 861 | 0% | 0 | 0 / 0 |
brain | 19% | 64.69 | 489 / 2642 | 45% | 2.93 | 318 / 705 |
eye | 0% | 0 | 0 / 0 | 49% | 2.96 | 39 / 80 |
muscle | 16% | 50.57 | 131 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0032355 | Biological process | response to estradiol |
GO_0001525 | Biological process | angiogenesis |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0045651 | Biological process | positive regulation of macrophage differentiation |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0007507 | Biological process | heart development |
GO_0045862 | Biological process | positive regulation of proteolysis |
GO_0030225 | Biological process | macrophage differentiation |
GO_0030101 | Biological process | natural killer cell activation |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0036462 | Biological process | TRAIL-activated apoptotic signaling pathway |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0045471 | Biological process | response to ethanol |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0097202 | Biological process | activation of cysteine-type endopeptidase activity |
GO_0045088 | Biological process | regulation of innate immune response |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0060546 | Biological process | negative regulation of necroptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0097264 | Biological process | self proteolysis |
GO_0042113 | Biological process | B cell activation |
GO_0006508 | Biological process | proteolysis |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0006915 | Biological process | apoptotic process |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0032025 | Biological process | response to cobalt ion |
GO_0060715 | Biological process | syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0042110 | Biological process | T cell activation |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0051604 | Biological process | protein maturation |
GO_0097342 | Cellular component | ripoptosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031265 | Cellular component | CD95 death-inducing signaling complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0044297 | Cellular component | cell body |
GO_0031264 | Cellular component | death-inducing signaling complex |
GO_0030027 | Cellular component | lamellipodium |
GO_0008233 | Molecular function | peptidase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0097153 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic process |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0097199 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0005123 | Molecular function | death receptor binding |
GO_0005164 | Molecular function | tumor necrosis factor receptor binding |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0035877 | Molecular function | death effector domain binding |
Gene name | CASP8 |
Protein name | Caspase 8 splice variant Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10] Caspase 8 CASP8 protein Caspase 8 isoform C Caspase-8 |
Synonyms | MCH5 |
Description | FUNCTION: Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood . Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for FAS/CD95-mediated and TNFRSF1A-induced cell death . Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 . Binding to the adapter molecule FADD recruits it to either receptor FAS/TNFRSF6 or TNFRSF1A . The resulting aggregate called the death-inducing signaling complex (DISC) performs CASP8 proteolytic activation . The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases . Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC . In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis: acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response . Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-C and -D (GSDMC and GSDMD, respectively): gasdermin cleavage promotes release of the N-terminal moiety that binds to membranes and forms pores, triggering pyroptosis . Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways . Cleaves PARP1 and PARP2 . Independent of its protease activity, promotes cell migration following phosphorylation at Tyr-380 . .; FUNCTION: [Isoform 5]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. .; FUNCTION: [Isoform 6]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. .; FUNCTION: [Isoform 7]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade . .; FUNCTION: [Isoform 8]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. . |
Accessions | ENST00000447616.6 [Q14790-6] E7ETB7 E7EQ01 ENST00000429881.2 C9JB29 ENST00000437283.5 ENST00000392258.7 [Q14790-5] ENST00000696087.1 [Q14790-2] E7EVN1 ENST00000264275.9 [Q14790-4] ENST00000392263.6 [Q14790-2] ENST00000413726.5 ENST00000440732.5 ENST00000447616.5 ENST00000696085.1 ENST00000696067.1 [Q14790-1] ENST00000432109.6 [Q14790-1] ENST00000413726.6 [Q14790-1] ENST00000444430.3 [Q14790-3] ENST00000696068.1 [Q14790-6] A0A8Q3WKY8 Q6NVI2 ENST00000339403.6 Q14790 ENST00000673742.1 [Q14790-1] ENST00000444430.2 B5BU46 ENST00000323492.11 [Q14790-2] ENST00000358485.8 [Q14790-9] B6CGU5 ENST00000450491.6 ENST00000696069.1 ENST00000440732.6 [Q14790-1] H7C0E2 F8WF39 A0A8Q3SI66 E7EQ06 A0A8Q3SID9 |